Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: A phase III trial (E2995)
- Peter L. Greenberg
- , Sandra J. Lee
- , Ranjana Advani
- , Martin S. Tallman
- , Branimir I. Sikic
- , Louis Letendre
- , Kathleen Dugan
- , Bert Lum
- , David L. Chin
- , Gordon Dewald
- , Elisabeth Paietta
- , John M. Bennett
- , Jacob M. Rowe
Research output: Contribution to journal › Article › peer-review
218
Link opens in a new tab
Scopus
citations